Post-operative treatment for patients treated with NWTS 5 protocol.

Table 1: Post-operative treatment for patients treated with NWTS 5 protocol.

Patients	Treatment regimen
Stage I Stage II favorable histology	EE-4A: 18 weeks with Vincristine and Actinomycin D
Stage III, IV favorable histology Stage II-IV focal anaplasia	DD-4A: 24 weeks with Vincristine, Actinomycin D and Doxorubicin Radiotherapy: 1.8Gy x 6 fractions = 10.8Gy
Stage II-IV diffuse anaplasia	I: 24 weeks with Vincristine, Doxorubicin, Cyclophosphamide and Etoposide Radiotherapy: 1.8Gy x 6 fractions = 10.8Gy